title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million,20240503T200500,https://www.globenewswire.com/news-release/2024/05/03/2875352/28652/en/Aileron-Therapeutics-Announces-Closing-of-Underwritten-Registered-Direct-Offering-of-up-to-Approximately-40-Million.html,PGPHF,0.090816,Neutral,0.093419
Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million - Aileron Therapeutics  ( NASDAQ:ALRN ) ,20240503T200500,https://www.benzinga.com/pressreleases/24/05/g38623996/aileron-therapeutics-announces-closing-of-underwritten-registered-direct-offering-of-up-to-approxi,PGPHF,0.087344,Neutral,0.088583
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million - Aileron Therapeutics  ( NASDAQ:ALRN ) ,20240501T124503,https://www.benzinga.com/pressreleases/24/05/g38549401/aileron-therapeutics-announces-pricing-of-underwritten-registered-direct-offering-priced-at-the-ma,PGPHF,0.08282,Neutral,0.098067
Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million,20240501T124500,https://www.globenewswire.com/news-release/2024/05/01/2873263/28652/en/Aileron-Therapeutics-Announces-Pricing-of-Underwritten-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules-of-up-to-Approximately-40-Million.html,PGPHF,0.08687,Neutral,0.10193
